Ocular Therapeutix (OCUL) Inventory (2014 - 2026)

Ocular Therapeutix has reported Inventory for 13 years, with the latest figure at $3.8 million in Q2 2026.

• Inventory for Q2 2026 came in at $3.8 million, up 25.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.8 million (up 25.9% YoY), and the FY2025 annual result was $3.6 million, up 17.24% from the prior year.
• Inventory improved to $3.8 million in Q2 2026, from $3.7 million in the prior quarter.
• Over five years, Inventory peaked at $3.8 million in Q2 2026 and troughed at $1.4 million in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.5 million in 2024 frame the typical range for Inventory.
• The widest annual swing landed in 2023, when Inventory soared 66.86%; it then grew 6.56% in 2024.
• A 5-year view of Inventory shows it stood at $2.0 million in 2022, then increased by 16.77% to $2.3 million in 2023, then surged by 31.89% to $3.0 million in 2024, then climbed by 17.24% to $3.6 million in 2025, then gained by 7.35% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $3.8 million in Q2 2026, $3.7 million in Q1 2026, and $3.6 million in Q4 2025.